Table 1.

Baseline characteristics of 64 subjects who had 25(OH)D levels measured while on statin therapy

	No myalgia	Myalgia
Subject variable	N = 25 (37.5%)	N = 39 (62.5%)	p-value*
Age Mean (SD)	59.3 (13.8)	59.5 (10.0)	0.95
Gender (Male, Female)	16/9	21/18	0.58
BMI Mean (SD)	27.5 (5.5)	27.9 (5.7)	0.77
25(OH)D (ng/mL) Mean (SD)	24.3 (10.5)	28.2 (11.6)	0.17
Statin (mg)			0.20
Atorvastatin (10, 20, 40)	7/1/1	13/4/1
Pravastatin (10, 20, 40)	0/0/2	5/2/0
Simvastatin (10, 20, 40)	4/4/1	3/2/1
Lovastatin (10, 20, 80)	0/1/1	3/2/0
Rosuvastatin (5, 10, 20)	0/1/1	1/2/2
Fluvastatin (20, 80)	0	4/1
Taking niacin, fenofibrate, diltiazem or verapamil	0	9

The doses for the various statins are listed in parentheses in mg and the number of subjects for each dose is indicated separated by /.

^*p values are based on a two-sample t-test, Chi-square test or Fisher's exact test as appropriate.